News
Article
Author(s):
Participants in the intervention group also reported themes of increased connectivity, creativity, and positivity.
Preliminary data from a small-scale pilot study suggested that use of a musical intervention program such as the “Lullaby Project” throughout pregnancy may help better stabilize quality of life (QOL) for expecting mothers with epilepsy. The study was limited in that it was not powered for statistical significance; however, investigators concluded that further benefits should be explored in larger sample sizes.1
In the trial, patients in a specialized epilepsy and pregnancy program received standard pregnancy and epilepsy care (control; n = 7) while the other received the same care with an added musical intervention (intervention; n = 10). The added intervention, known as the Lullaby Project, pairs new and expecting parents and caregivers with progressional artists to write and sing personal lullabies for their babies, supporting maternal health, aiding childhood development, and strengthening the bond between parent and child.
Presented at the 2024 American Epilepsy Society (AES) Annual Meeting, held December 6-10 in Los Angeles, California, participants completed self-reported measures of epilepsy-related quality of life (QOLIE-31-P) and stress and anxiety symptoms (DASS-21) at baseline and approximately every three weeks over a 10-week period. Over that time period (range, 9-29 weeks), those in the intervention group showed a change of –0.21 in QOLIE-31-P scores whereas those in the control group had changes of –3.78 on the same measure.
Led by Sharon Ng, BASc, a graduate student at Harvard University, the changes suggested a trend towards greater positive stabilization through the added intervention, although this did not reach statistical significance (P = .23), likely because of the small sample size. The study authors also noted that the intervention group also demonstrated emerging themes of positive feelings such as connectivity, creativity, and positivity in the intervention group. Notably, 9 of 10 participants in the intervention cohort completed the study while only 4 of 7 did for the control group, further supporting the intervention’s feasibility.
READ MORE: Relutrigine Shows Promise in Phase 2 EMBOLD Study of SCN2A-DEE and SCN8A-DEE
At baseline, investigators collected data on several different demographic measurables for both groups. These included mean age of participants (intervention: 33.9 yr vs control: 35.0 yr; P = .92), gestational age (intervention: 24.7 wks vs control: 19.3 wks; P = .20), mean QOLIE-31-P scores (intervention: 47.5 vs controls: 51.4; P = .31), mean DASS-21 anxiety scores (intervention: 5.1 vs control: 7.4; P = .56). Overall, the average length for participants to complete the intervention was 18 weeks (range, 9-29).
Using music as a therapeutic strategy during pregnancy has been researched before, with mixed results thus far. There have been some evidence to suggest that listening to Mozart’s music, short-term and long-term, may contribute to decreases in epileptiform discharge and seizure frequency in children with epilepsy, even in refractory types; however, this has been regarded as a myth by many.2,3
A 2023 multiverse meta-analysis revealed that listening to music, let alone a specific kind of sonata, does not appear to have any beneficial effect on epilepsy. In that analysis, investigators concluded that unfounded authority, underpowered studies, and nontransparent reporting are among the main drivers of the Mozart effect myth. Using 3 independent analyses, the study authors found nonsignificant trivial-to-small summary effects for listening to Mozart KV448 or other musical stimuli on epilepsy or other medical conditions (g range: 0.03-0.43).3
Click here for more AES 2024 coverage.